AccuStem Sciences and EmeritusDX Expand Blood-Based Cancer Testing Capabilities with Advanced miRNA Platform

AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, annou...

September 18, 2025 | Thursday | News
Sanofi’s Brivekimig Demonstrates Positive Phase 2a Results in Moderate-to-Severe Hidradenitis Suppurativa

In phase 2a study, brivekimig led to clinically meaningful improvements in primary and key secondary endpoints in biologic-naïve patients compared...

September 18, 2025 | Thursday | News
Cenevo Launches Labguru Assistant to Bring AI-Driven Support Directly Into Scientists’ Daily Work

Cenevo is launching the Labguru Assistant, an AI-enabled extension to the Labguru solution designed to provide scientists with real-time, in-platform suppo...

September 18, 2025 | Thursday | News
Celltrion Pharm Signs Strategic Trilateral Agreement with BD to Boost Global Prefilled Syringe CMO Business

-Celltrion Pharm , a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a multination...

September 17, 2025 | Wednesday | News
Galimedix Completes Phase 1 Trial of Oral GAL-101, Advancing Toward Phase 2 in Alzheimer’s Disease

GAL-101 was well tolerated; excellent safety and pharmacokinetic profile strongly support oral administration GAL-101 effectively crosses the blood-br...

September 15, 2025 | Monday | News
Belite Bio Completes Phase 3 DRAGON Trial of Tinlarebant in Stargardt Disease

Tinlarebant has been granted Breakthrough Therapy, Fast Track, and Rare Pediatric Disease Designations in the U.S.; Orphan Drug Designation in the U.S....

September 15, 2025 | Monday | News
AVITA Medical Secures CE Mark for RECELL® GO, Expanding European Access to Innovative Burn Care

- AVITA Medical, Inc., a leading therapeutic acute wound care company,announced it has received the CE Mark under the European Union Medical Device Regul...

September 15, 2025 | Monday | News
Pioneering DNA Innovator Dr. Martin Schleef Wins NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the Innovation Award 2025 of the State ...

September 11, 2025 | Thursday | News
QIAGEN Secures CE-IVDR Certification for Full QIAstat-Dx Portfolio, Expands Syndromic Testing Panels

Full portfolio of QIAstat-Dx panels now CE-IVDR certified for use in clinical syndromic testing, underscoring commitment to highest-quality diagnosti...

September 11, 2025 | Thursday | News
Cellworks myCare-040 Study Demonstrates Predictive Power of Computational Modeling to Guide Chemo-Immunotherapy Decisions in Advanced NSCLC

-Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Best-in-Class PTRS, announced results from the landmark myCare-040 clinical ...

September 09, 2025 | Tuesday | News
IFF Expands LMR Naturals Site in Grasse with €10 Million Investment to Drive Next-Generation Natural Ingredient Innovation

-IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences,  inaugurated its expanded LMR Naturals site in Grasse fo...

September 09, 2025 | Tuesday | News
Johnson & Johnson Expands ACUVUE® Portfolio with Breakthrough Toric Lenses in Europe and Middle East

World’s #1 Selling Contact Lens Brand ACUVUE® brings pioneering innovation for astigmatic patients, providing visual clarity and comfort Johns...

September 08, 2025 | Monday | News
Biocodex Leads €55M Series B with €11M Strategic Investment in MRM Health to Advance Microbiome-Based Therapeutics

Biocodex, a French family-owned pharmaceutical pioneer in microbiota research for over 70 years, announces a strategic equity investment of €11 mill...

September 05, 2025 | Friday | News
CrystalsFirst and NexMR Forge Exclusive Partnership to Accelerate Fragment-Based Drug Discovery

 CrystalsFirst GmbH, a leader in high-performance structural biology services, and NexMR AG, a pioneer in ultrafast NMR screening,  announ...

September 05, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close